Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Touraine

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Pediatrie|January 1, 1992
[Genetics and hyperphenylalaninemias in 1992]R L Touraine, P Guibaud
La Revue Du Praticien|April 11, 1986
[Kaposi's sarcoma and AIDS]P Saïag, R L Touraine
Journal of Neurology|March 3, 2006
Chronic neuromyotonia as a phenotypic variation associated with a new mutation in the KCNA1 geneA Poujois, J-Ch Antoine, A Combes, et al.
Human Gene Therapy|November 26, 1998
Enhancement of the herpes simplex virus thymidine kinase/ganciclovir bystander effect and its antitumor efficacy in vivo by pharmacologic manipulation of gap junctionsR L Touraine, N Vahanian, W J Ramsey, et al.
European Journal of Pediatrics|August 1, 1993
Hepatic tumours during androgen therapy in Fanconi anaemiaR L Touraine, Y Bertrand, P Foray, et al.
European Journal of Pediatrics|February 24, 2001
Impaired autonomic control of the heart by SOX10 mutationE Korsch, J Steinkuhle, M Massin, et al.
Gene Therapy|February 19, 1999
The bystander effect in the HSVtk/ganciclovir system and its relationship to gap junctional communicationR L Touraine, H Ishii-Morita, W J Ramsey, et al.
The American Journal of Medicine|April 1, 1988
Failure of warfarin in treatment of calcinosis universalisK Lassoued, P Saiag, M C Anglade, et al.
Pediatrie|January 1, 1991
[Candida albicans arthritis during induction treatment of acute lymphoblastic leukemia]R L Touraine, Y Bertrand, C Nakache, et al.
Human Mutation|January 1, 1995
A 13-bp deletion (1952 del 13) in the methylmalonyl CoA mutase gene of an affected patientR L Touraine, M O Rolland, P Divry, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Pediatrie|January 1, 1992
[Genetics and hyperphenylalaninemias in 1992]R L Touraine, P Guibaud
La Revue Du Praticien|April 11, 1986
[Kaposi's sarcoma and AIDS]P Saïag, R L Touraine
Journal of Neurology|March 3, 2006
Chronic neuromyotonia as a phenotypic variation associated with a new mutation in the KCNA1 geneA Poujois, J-Ch Antoine, A Combes, et al.
Human Gene Therapy|November 26, 1998
Enhancement of the herpes simplex virus thymidine kinase/ganciclovir bystander effect and its antitumor efficacy in vivo by pharmacologic manipulation of gap junctionsR L Touraine, N Vahanian, W J Ramsey, et al.
European Journal of Pediatrics|August 1, 1993
Hepatic tumours during androgen therapy in Fanconi anaemiaR L Touraine, Y Bertrand, P Foray, et al.
European Journal of Pediatrics|February 24, 2001
Impaired autonomic control of the heart by SOX10 mutationE Korsch, J Steinkuhle, M Massin, et al.
Gene Therapy|February 19, 1999
The bystander effect in the HSVtk/ganciclovir system and its relationship to gap junctional communicationR L Touraine, H Ishii-Morita, W J Ramsey, et al.
The American Journal of Medicine|April 1, 1988
Failure of warfarin in treatment of calcinosis universalisK Lassoued, P Saiag, M C Anglade, et al.
Pediatrie|January 1, 1991
[Candida albicans arthritis during induction treatment of acute lymphoblastic leukemia]R L Touraine, Y Bertrand, C Nakache, et al.
Human Mutation|January 1, 1995
A 13-bp deletion (1952 del 13) in the methylmalonyl CoA mutase gene of an affected patientR L Touraine, M O Rolland, P Divry, et al.
Pageof 2